Answer
The intravenous formulation is licensed for selected adults with moderately to severely active chronic pouchitis after ulcerative-colitis surgery when antibiotics have not worked adequately or have lost effect. The subcutaneous formulation is not licensed for pouchitis.
Sources for this answer
- Entyvio 108 mg solution for injection in pre-filled syringe — Current selected SmPCemc · Summary of Product Characteristics
- Entyvio 300 mg powder for concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.